Viewing nowCombinationAibastar Tablet 5/160 mg
Valsartan 160mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Huons Life Science Co., Ltd.

MFDS item code 201705678 · Approved 2017.07.14 · Insurance code 052701170
Improvement in blood pressure control for essential hypertension via the combination of amlodipine and valsartan
This medication is indicated for patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan, allowing effective lowering and management of blood pressure. It combines the effects of both components to help dilate blood vessels and maintain stable blood pressure. Therefore, this medication can contribute to preventing complications and maintaining a healthy state in cases where blood pressure control is challenging.
The recommended dosage for adults is one tablet once daily, taken with water irrespective of meals. It is recommended to take it at the same time each day (e.g., in the morning). Patients with high blood pressure inadequately controlled with 5 mg amlodipine or 80 mg valsartan monotherapy should take the 5/80 mg formulation. Patients with high blood pressure inadequately controlled with 5 mg amlodipine or 160 mg valsartan monotherapy should take the 5/160 mg formulation.
Safety and efficacy for pediatric patients under 18 years of age have not been established, and administration of this medication is not recommended.
This medication should not be taken during the second and third trimesters of pregnancy, as it can cause serious harm or death to the fetus; discontinue immediately upon confirmation of pregnancy. Those with allergies to this medication's active ingredients or to drugs in a similar category should not take it. Pregnant or nursing women, as well as those with severe kidney or liver dysfunction, should not take this medication. Patients with deficiencies in fluid or sodium should improve their condition before taking this medication; if symptoms of hypotension occur during treatment, lie down immediately and seek medical assistance if necessary. Patients with high potassium levels or those taking potassium supplements should monitor their potassium levels regularly. Patients with renal artery stenosis or those who have recently undergone kidney transplants should closely monitor kidney function when using this medication. If symptoms of angioedema occur, discontinue use immediately and do not re-administer. Patients with heart failure or post-myocardial infarction should periodically check kidney function and blood pressure while taking this medication, and consider the risk of pulmonary edema. Patients with acute myocardial infarction, aortic stenosis, or obstructive hypertrophic cardiomyopathy require special caution when using this medication. When combined with other antihypertensive medications, this medication may increase the risk of hypotension, hyperkalemia, and worsening kidney function; therefore, regular monitoring of blood pressure and blood tests is necessary as directed by a physician. Caution is needed when driving or operating machinery, as dizziness or fatigue may occur. In cases of overdose, severe hypotension or cardiac issues may result, so prescribed dosages must be adhered to, and you should seek immediate medical attention if any abnormal symptoms occur. This medication is not recommended for children under 18 years of age as safety and efficacy have not been established. The same dosage is recommended for the elderly as for adults, but caution may be warranted depending on the condition. Regular liver and kidney function tests are advisable during treatment, and consult a physician immediately if any abnormal symptoms arise.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral or ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination issues
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.
Dark yellow, rectangular film-coated tablet
28 tablets/box[(14 tablets/Alu-Alu X 2)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Huons Life Science Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.